Авторы

  • Халимова Х.М., Якубова М.М., Парпиева Ю.Р.

Ключевые слова:

тарқоқ склероз, клиник-радиологик диссоциация, цитокинлар, иммунологик кўрсаткичлар, яллиғланиш.

Библиографические ссылки

Ахмедов, Н.К. (2017). Тарқоқ склерознинг клиник таснифи ва даволаш усуллари. Тошкент тиббиёт журнали, 1(3), 24-30.

.Шамсиев, О.К. (2019). Тарқоқ склерозда глюкокортикостероидларни қўллаш. Клиник тиббиёт журнали, 3(4), 30-37.

Colomba, P., Fontana, S., Salemi, G., et al. (2014). Identification of Biomarkers in Cerebrospinal Fluid and Serum of Multiple Sclerosis Patients by Immunoproteomics Approach. International Journal of Molecular Sciences, 15, 23269-23282.

Das, S., Angsantikul, P., Le, C., et al. (2018). Neutralization of cholera toxin with nanoparticle decoys for treatment

De Stefano, N. (2020). Response to Dr. Boyko’s letter: ‘Radiologically isolated syndrome with oligoclonal bands in CSF (RIS + OCB) can be classified as highly MS-risk group’. Multiple Sclerosis Journal, 26, 871-871.

Fiedler, S. E., George, J. D., Love, H. N., et al. (2017). Analysis of IL-6, IL-1β, and TNF-α production in monocytes isolated from multiple sclerosis patients treated with disease-modifying drugs. Journal of Systems and Integrative Neuroscience, 3(3).

Halimova H.M., Parpiyeva Y.R., Rashidova N.S., Urmanova Y.M. Immunological and neurohormonal changes in women with multiple sclerosis during pregnancy and disease outcomes // 08 May 2021y.- Annals of R.S.C.B., ISSN:1583-6258, Vol. 25, Issue

Hauser, S.L., & Cree, B.A. (2020). Treatment of Multiple Sclerosis: A Review. The American Journal of Medicine.

Kumar, N., Sharma, N., & Mehan, S. (2021). Connection between JAK/STAT and PPARγ signaling during the progression of multiple sclerosis: Insights into the modulation of T-cells and immune responses in the brain. Current Molecular Pharmacology.

Libbey J. E., Lane T., Fujinami R. (2014). Axonal pathology and demyelination in viral models of multiple sclerosis. Discovery Medicine, 18(97),79-89.

Mouzaki, A., Rodi, M., Dimisianos, N., et al. (2015). Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation. PLoS ONE, 10.

Sosvorová, L., Kančeva, R., Vcelak, J., et al. (2015). The comparison of selected cerebrospinal fluid and serum cytokine levels in patients with multiple sclerosis and normal pressure hydrocephalus. Neuro Endocrinology Letters, 36(6), 564-571.

Yao, S., Xu, H., Zhang, H., et al. (2020). Targeting of Th1/Th17 and Th17/Treg imbalance in multiple sclerosis. Journal of Immunology Research, 2020, 153923.

Yu, L., Qin, L., et al. (2018). The effects of microbiota on inflammation and immune response in MS. Frontiers in Immunology, 9, 900-910.

Zahid, M., Busmail, A., Penumetcha, S. S., Ahluwalia, S., Irfan, R., Khan, S. A., Reddy, S. R., Lopez, M. E. V., & Mohammed, L. (2021). Tumor Necrosis Factor Alpha Blockade and Multiple Sclerosis: Exploring New Avenues. Cureus, 13.